Targeted interventions could help reduce pre-test anxiety, improve the physical screening experience, and address structural barriers in underserved settings.
Pitting three multipurpose LLMs against two healthcare-specific AI tools, researchers have discovered the consumer-level AI can beat its purpose-built counterparts in healthcare scenarios—and soundly, at that.
The lawsuit dates back to 2019 but has been stuck in the court process for years. In the end, the health plan will pay Pomona Valley Hospital for emergency care delivered to patients at an out-of-network rate—though the facility didn’t get all of what it was seeking.
State Attorney General James Uthmeier is forcing the company to hand over thousands of documents related to its pharmacy contracts and reimbursement policies to see if the retail giant is abusing its position in the market as both a pharmacy benefit manager and a retail chain of drug stores.
Researchers are hopeful that a new technology named after a tentacled folklore sea monster can help scientists better understand the anatomy of the brain.
Widaplik, the new polypill from George Medicines, includes telmisartan, amlodipine and indapamide. The FDA's decision comes after positive data were published in both JACC and The Lancet.
Consulting firm Vizient is forecasting continued growth in the specialty, driven by shifts in where patients receive care, new therapies that require imaging and a rapidly aging population.
![Performing transcatheter aortic valve replacement (TAVR) with the J-Valve transcatheter heart valve (THV) may help limit the risk of coronary artery obstruction (CAO) in high-risk patients, according to a new study published in Clinical Interventions in Aging.[1]](/sites/default/files/styles/stack_views/public/2024-10/screenshot_2024-10-01_at_2.16.21_pm.png.webp?itok=qOxNPyOr)
